Cargando…
Dual Biologic Therapy in Patients with Familial Mediterranean Fever and Spondyloarthritis: Case-Based Review
Patients with familial Mediterranean fever and spondylitis often fail to respond to conventional and biologic therapies. Achieving remission in these patients usually requires conventional and biologic treatment combinations. Combination of biologic agents may be a promising option for patients with...
Autores principales: | Yıldırım, Derya, Kardaş, Rıza Can, Özkızıltaş, Burcugul, Vasi, İbrahim, Küçük, Hamit, Öztürk, Mehmet Akif, Tufan, Abdurrahman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mesut Onat
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152114/ https://www.ncbi.nlm.nih.gov/pubmed/35943463 http://dx.doi.org/10.5152/EuJRheum.2022.21180 |
Ejemplares similares
-
Factors affecting patient-acceptable symptom states and treatment decision in familial Mediterranean fever
por: YILDIRIM, Derya, et al.
Publicado: (2022) -
Investigation of the value of hematological biomarkers in the clinical differential diagnosis of IgG4-RD
por: KARADENİZ, Hazan, et al.
Publicado: (2023) -
Magnetic resonance imaging features of Familial Mediterranean Fever associated spondyloarthritis
por: Turan, A, et al.
Publicado: (2015) -
Serum ferritin as an activity marker for granulamotosis with polyangiitis
por: Kucuk, Hamit, et al.
Publicado: (2017) -
Predictive value of neutrophil/lymphocyte ratio in renal prognosis of patients with granulomatosis with polyangiitis
por: Küçük, Hamit, et al.
Publicado: (2016)